Cargando…
A case report involving suppressed nuclear receptor transcription factors 4a1 and Stevens-Johnson syndrome induced by a single dose of pembrolizumab and successfully treated with early steroid administration, resulting in complete remission of stage III lung cancer
BACKGROUND: Immunotherapy with immune checkpoint inhibitors is associated with immune-related adverse events (irAEs). A positive correlation between treatment efficacy and irAEs has been reported. Clinical indicators are required for appropriate interventions, such as steroid administration, to prev...
Autores principales: | Machida, Maiko, Yamazaki, Chika, Kouda, Nao, Hanai, Yousei, Sato, Hideki, Konda, Ainari, Yamagata, Yuka, Itho, Tatsuya, Aisaka, Haruhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720965/ https://www.ncbi.nlm.nih.gov/pubmed/36464708 http://dx.doi.org/10.1186/s40780-022-00261-y |
Ejemplares similares
-
Stevens-Johnson syndrome and abuse of anabolic steroids
por: Cocca, Serena, et al.
Publicado: (2017) -
Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016) -
"Síndrome de Stevens-Johnson"
por: Mortera Carbonell, María de los Angeles
Publicado: (1992) -
Stevens Johnson Syndrome – “Steven Who? And Why I Should Care About His Johnson?”
por: Cardon, Zachary E., et al.
Publicado: (2019) -
Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab
por: Lopez, Michael, et al.
Publicado: (2023)